POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Clinical trials for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo dosing shows promise for kids with rare cancers
Disease control CompletedThis study tested a new way of giving chemotherapy called dose-adjusted EPOCH-R in children with certain B-cell cancers (DLBCL, PMBCL, or PTLD). The goal was to see if it is safe and could improve cure rates while reducing side effects, as it has in adults. Only 4 children took p…
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Virus watch: study tracks EBV in kidney transplant patients to prevent cancer and infection
Knowledge-focused CompletedThis study followed 509 kidney transplant recipients to see if regularly checking Epstein-Barr virus (EBV) levels in blood could predict serious infections, a type of cancer called PTLD, or death. The goal was to learn how to better adjust immune-suppressing drugs for each patien…
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 17, 2026 03:12 UTC